Kurokawa K - Search Results

1

Abnormal iron deposition in renal cells in the rat with chronic angiotensin II administration.

Ishizaka N, Aizawa T, Yamazaki I, Usui S, Mori I, Kurokawa K, Tang SS, Ingelfinger JR, Ohno M, Nagai R. Ishizaka N, et al. Among authors: kurokawa k. Lab Invest. 2002 Jan;82(1):87-96. doi: 10.1038/labinvest.3780398. Lab Invest. 2002. PMID: 11796829 Free article.

2

Transdifferentiation of cultured tubular cells induced by hypoxia.

Manotham K, Tanaka T, Matsumoto M, Ohse T, Inagi R, Miyata T, Kurokawa K, Fujita T, Ingelfinger JR, Nangaku M. Manotham K, et al. Among authors: kurokawa k. Kidney Int. 2004 Mar;65(3):871-80. doi: 10.1111/j.1523-1755.2004.00461.x. Kidney Int. 2004. PMID: 14871406 Free article.

3

Renoprotective properties of angiotensin receptor blockers beyond blood pressure lowering.

Izuhara Y, Nangaku M, Inagi R, Tominaga N, Aizawa T, Kurokawa K, van Ypersele de Strihou C, Miyata T. Izuhara Y, et al. Among authors: kurokawa k. J Am Soc Nephrol. 2005 Dec;16(12):3631-41. doi: 10.1681/ASN.2005050522. Epub 2005 Oct 19. J Am Soc Nephrol. 2005. PMID: 16236804

4

Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury.

Shao J, Nangaku M, Miyata T, Inagi R, Yamada K, Kurokawa K, Fujita T. Shao J, et al. Among authors: kurokawa k. Hypertension. 2003 Jul;42(1):31-8. doi: 10.1161/01.HYP.0000075082.06183.4E. Epub 2003 May 27. Hypertension. 2003. PMID: 12771047

5

Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model.

Nangaku M, Miyata T, Sada T, Mizuno M, Inagi R, Ueda Y, Ishikawa N, Yuzawa H, Koike H, van Ypersele de Strihou C, Kurokawa K. Nangaku M, et al. Among authors: kurokawa k. J Am Soc Nephrol. 2003 May;14(5):1212-22. doi: 10.1097/01.asn.0000062961.76776.c1. J Am Soc Nephrol. 2003. PMID: 12707391

6

ET(B) receptor protects the tubulointerstitium in experimental thrombotic microangiopathy.

Nangaku M, Yamada K, Gariepy CE, Miyata T, Inagi R, Kurokawa K, Yanagisawa M, Fujita T, Johnson RJ. Nangaku M, et al. Among authors: kurokawa k. Kidney Int. 2002 Sep;62(3):922-8. doi: 10.1046/j.1523-1755.2002.00519.x. Kidney Int. 2002. PMID: 12164874 Free article.

7

Hypoxia-induced apoptosis in cultured glomerular endothelial cells: involvement of mitochondrial pathways.

Tanaka T, Miyata T, Inagi R, Kurokawa K, Adler S, Fujita T, Nangaku M. Tanaka T, et al. Among authors: kurokawa k. Kidney Int. 2003 Dec;64(6):2020-32. doi: 10.1046/j.1523-1755.2003.00301.x. Kidney Int. 2003. PMID: 14633124 Free article.

8

Evidence of tubular hypoxia in the early phase in the remnant kidney model.

Manotham K, Tanaka T, Matsumoto M, Ohse T, Miyata T, Inagi R, Kurokawa K, Fujita T, Nangaku M. Manotham K, et al. Among authors: kurokawa k. J Am Soc Nephrol. 2004 May;15(5):1277-88. doi: 10.1097/01.asn.0000125614.35046.10. J Am Soc Nephrol. 2004. PMID: 15100368

9

Sphingosine 1-phosphate stimulates rat mesangial cell proliferation from outside the cells.

Hanafusa N, Yatomi Y, Yamada K, Hori Y, Nangaku M, Okuda T, Fujita T, Kurokawa K, Fukagawa M. Hanafusa N, et al. Among authors: kurokawa k. Nephrol Dial Transplant. 2002 Apr;17(4):580-6. doi: 10.1093/ndt/17.4.580. Nephrol Dial Transplant. 2002. PMID: 11917049

10

Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes: a subanalysis of Japanese patients from the RENAAL study.

Kurokawa K, Chan JC, Cooper ME, Keane WF, Shahinfar S, Zhang Z. Kurokawa K, et al. Clin Exp Nephrol. 2006 Sep;10(3):193-200. doi: 10.1007/s10157-006-0427-6. Clin Exp Nephrol. 2006. PMID: 17009077 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,532 results

Search Page

Filters